TP53 and neoplasm: NVP-LDE-225 and NVP-BEZ-235 inhibited the self-renewal capacity of pancreatic CSCs isolated from human and Pankras/p53 mice in vitro, and CSC's tumor growth in NOD/SCID IL2RΥ null mice, and synergetic effect was observed when both drugs were used in combination.